‘Grandma and grandpa aren’t going to figure this one out.’ Prescription-drug savings vanish in the Medicare shuffle

Biogen’s blockbuster multiple sclerosis drug Tecfidera is an example of how patients don’t always benefit from low-cost generic competition, researchers say